Helus Pharma Inc.(HELP)

Medical - Pharmaceuticals · Toronto, ON

$10.64-0.78 (-6.83%)

Delayed quote: Oct 6, 2026, 3:35 PM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T19:36:55.792Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:36:55.792Z.

Quote observation: 2026-10-06T19:35:13.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-06-30: -152,969,441
Quote market capitalization: 659,510,845

FMP input reference: 934548bd97ab8c390298f716fcf622fc2d1107cfab085c47b2b47650fd31fbc6

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

HELP Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

HELP Competitors' Operating Cash Flow Yield

HELP

Helus Pharma Inc.

Current

Market Cap

$659.51M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

STLN

Starling Oncology, Inc.

vs HELP

Market Cap

$658.89M

Operating Cash Flow Yield

0.05%

TTM Avg

0.05%

3Y Avg

0.05%

5Y Avg

0.05%

FDMT

4D Molecular Therapeutics, Inc.

vs HELP

Market Cap

$660.25M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDXG

MiMedx Group, Inc.

vs HELP

Market Cap

$660.28M

Operating Cash Flow Yield

6.99%

TTM Avg

9.30%

3Y Avg

5.99%

5Y Avg

5.99%

ANNX

Annexon, Inc.

vs HELP

Market Cap

$665.12M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AVBP

ArriVent BioPharma, Inc.

vs HELP

Market Cap

$676.27M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SLDB

Solid Biosciences Inc.

vs HELP

Market Cap

$676.87M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PRME

Prime Medicine, Inc.

vs HELP

Market Cap

$636.50M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FTH

Faeth Therapeutics, Inc.

vs HELP

Market Cap

$683.91M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VSTM

Verastem, Inc.

vs HELP

Market Cap

$684.40M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
Helus Pharma Inc. (HELP)	$659.51M	N/A	N/A	N/A	N/A
Starling Oncology, Inc. (STLN)vs ›	$658.89M	0.05%	0.05%	0.05%	0.05%
4D Molecular Therapeutics, Inc. (FDMT)vs ›	$660.25M	N/A	N/A	N/A	N/A
MiMedx Group, Inc. (MDXG)vs ›	$660.28M	6.99%	9.30%	5.99%	5.99%
Annexon, Inc. (ANNX)vs ›	$665.12M	N/A	N/A	N/A	N/A
ArriVent BioPharma, Inc. (AVBP)vs ›	$676.27M	N/A	N/A	N/A	N/A
Solid Biosciences Inc. (SLDB)vs ›	$676.87M	N/A	N/A	N/A	N/A
Prime Medicine, Inc. (PRME)vs ›	$636.50M	N/A	N/A	N/A	N/A
Faeth Therapeutics, Inc. (FTH)vs ›	$683.91M	N/A	N/A	N/A	N/A
Verastem, Inc. (VSTM)vs ›	$684.40M	N/A	N/A	N/A	N/A

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

HELP Operating Cash Flow Yield Metrics

HELP Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics